Mass Spectrometric and Contactless Conductivity Detection Approaches in the Determination of Muscle Relaxants by Capillary Electrophoresis

Analytical Letters

Volumn 46, Issue 14, 2013, Pages 2165-2179

  Petru K ^a   Moreno Gonzalez D ^b   Bohmova L ^a   Garcia Campana A M ^b   Polasek M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Capacitively coupled contactless conductivity detection; CE ESI MS; Muscle relaxants; Pancuronium; Rocuronium; Vecuronium

Indexed keywords

EID: 84884256388     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032719.2013.798798     Document Type: Article

References (23)

1. Ballard, K. D., W. E. Vickery, L. T. Nguyen, F. X. Diamond, and F. Rieders. 2006. An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument. J. Am. Soc. Mass Spectr. 17 (10): 1456 - 1468.
2. Blazewicz, A., Z. Fijalek, K. Sarna, and M. Warowna-Grzeskiewicz. 2010. Determination of Pancuronium and Its Impurities in Pharmaceutical Preparation by LC with Charged Aerosol Detection. Chromatographia 72 (1-2): 183 - 186.
3. Blaewicz, A., Z. Fijalek, M. Warowna-Grzeskiewicz, and M. Boruta. 2007. Simultaneous determination of rocuronium and its eight impurities in pharmaceutical preparation using high-performance liquid chromatography with amperometric detection. J. Chromatogr. A 1149 (1): 66 - 72.
4. Cirimele, V., M. Villain, G. Pepin, B. Ludes, and R. Kintz. 2003. Screening procedure for eight quaternary nitrogen muscle relaxants in blood by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 789 (1): 107 - 113.
5. Council of Europe, European Directorate for the Quality of Medicines. 2008. European Phaarmacopoeia, 6th ed. Strasbourg: Council of Europe.
6. Jansen, F. H. J. (Oud Turnhout, BE). 1997. Process to prepare pharmaceutical compositions containing vecuronium bromide and compositions produced thereby. U.S. Patent 5681573, filled August 8, 1995, and issued October 28, 1997.
7. Kala, M., and W. Lechowicz. 2004. Instability of pancuronium in postmortem blood and liver taken after a fatal intramuscular Pavulon injection. Forensic Sci. Int. 143 (2-3): 191 - 198.
8. Kleef, U. W., J. H. Proost, and J. Roggeveld. 1993. Determination of rocuronium and its putative metabolites in body-fluids and tissue-homogenates. J Chromatogr. B 621 (1): 65 - 76.
9. Lopez-Garcia, P., F. Pereira-Gomes, M. I. R. Miritello-Santoro, and E. R. M. Kedor-Hackmann. 2008. Validation of an HPLC analytical method for determination of pancuronium bromide in pharmaceutical injections. Anal. Lett. 41 (10): 1895 - 1908.
10. Lopez-Garcia, P., F. Pereira-Gomes, M. I. R. Miritello-Santoro, E. R. M. Kedor-Hackmann, J. L. Vilchez-Quero, A. Navalon-Monton, G. Crovetto-Montoya, and M. Aguilera-Cabrera. 2011. Determination of vecuronium bromide in pharmaceuticals: Development, validation and comparative study of HPLC and CZE analytical methods. Chromatographia 73 (7-8): 799 - 805.
11. Naguib, M. 2007. Sugammadex: Another milestone in clinical neuromuscular pharmacology. Anesth. Analg. 104 (3): 575 - 581.
12. 4D). J. Pharm. Biomed. Anal. 49 (2): 333 - 337.
13. Ohnesorge, J., C. Neususs, and H. Watzig. 2005. Quantitation in capillary electrophoresis-mass spectrometry. Electrophoresis 26 (21): 3973 - 3987.
14. Paton, F., M. Paulden, D. Chambers, M. Heirs, S. Duffy, J. M. Hunter, M. Sculpher, and N. Woolacott. 2010. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Brit. J. Anaesth. 105 (5): 558 - 567.
15. Petru, K., P. Jac, V. Luzova, J. Kunes, and M. Polasek. 2011. Determination of muscle relaxants pancuronium and vecuronium bromide by capillary electrophoresis with capacitively coupled contactless conductivity detection. Electrophoresis 32 (8): 890 - 895.
16. Probst, R., M. Blobner, P. Luppa, and D. Neumeier. 1997. Quantification of the neuromuscular blocking agent rocuronium and its putative metabolite 17-desacetylrocuronium in heparinized plasma by capillary gas chromatography using a nitrogen sensitive detector. J. Chromatogr. B 702 (1-2): 111 - 117.
17. Simo, C., and A. Cifuentes. 2005. Mass spectrometry detection in capillary electrophoresis. In Analysis and Detection by Capillary Electrophoresis, 1st ed., ed. M. L. Marina, A. Ríos, and M. Valcárcel. Amsterdam: Elsevier.
18. United States Pharmacopoeial Convention. 2011. The United States Pharmacopoeia, Vol. 35. Rockville: United States Pharmacopoeial Convention.
19. Usui, K., T. Hishinuma, H. Yamaguchi, T. Saga, T. Wagatsuma, K. Hoshi, N. Tachiiri, K. Miura, and J. Goto. 2006. Simultaneous determination of pancuronium, vecuronium and their related compounds using LC-ESI-MS. Leg. Med. 8 (3): 166 - 171.
20. Wedig, M., N. Novatchev, T. Worch, S. Laug, and U. Holzgrabe. 2002. Evaluation of the impurity profile of alcuronium by means of capillary electrophoresis. J. Pharm. Biomed. Anal. 28 (5): 983 - 990.
21. Welliver M. 2006. New drug sugammadex: A selective relaxant binding agent. AANA J. 74 (5): 357 - 363.
22. Welliver, M., J. McDonough, N. Kalynych, and R. Redfern. 2009. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent. Drug Des. Devel. Ther. 2: 49 - 59.
23. Zecevic, M., L. Zivanovic, and A. Stojkovic. 2002. Validation of a high-performance liquid chromatography method for the determination of pancuronium in Pavulon injections. J. Chromatogr. A 949 (1-2): 61 - 64.